Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
---|
11/09/2000 | WO2000066120A1 Novel catechols as antimicrobial agents |
11/09/2000 | CA2372079A1 Novel catechols as antimicrobial agents |
11/09/2000 | CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
11/09/2000 | CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof |
11/09/2000 | CA2369077A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives |
11/08/2000 | EP1049679A2 Sulphonamide derivatives for treatment of cns disorders |
11/08/2000 | EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
11/07/2000 | US6143895 Quinoline derivatives and quinoline combinatorial libraries |
11/07/2000 | US6143770 Mixtures of tocotrienol and nicotinic acid |
11/07/2000 | US6143764 Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same |
11/07/2000 | US6143763 Carbostyril derivatives |
11/07/2000 | CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them |
11/02/2000 | WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands |
11/02/2000 | WO2000064877A1 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
11/02/2000 | WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands |
11/02/2000 | EP1048694A1 Azo compounds and process for producing the same |
11/02/2000 | EP1048655A1 1,2-dihydro-2-oxoquinoline derivatives |
11/02/2000 | EP1048296A1 Drugs augmenting nkt cells |
11/02/2000 | EP1047691A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists |
11/02/2000 | CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands |
11/01/2000 | CN1272107A Benzamidine derivatives as factor Xa inhibitors |
10/31/2000 | US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
10/31/2000 | US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents |
10/31/2000 | US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity |
10/31/2000 | US6140342 Cholesteryl ester transfer protein inhibitor; used to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as ldl-cholesterol and triglycerides |
10/31/2000 | US6140341 For treating pain |
10/26/2000 | WO2000039082A3 1,2-annelated quinoline derivatives |
10/25/2000 | CN1271357A bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
10/25/2000 | CN1271348A Method for producing (hetero) aromatic hydroxylamines |
10/24/2000 | US6136985 CLA esters and uses thereof |
10/24/2000 | US6136823 Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient |
10/24/2000 | US6136822 Quinolinone derivative, method for preparing the same, and anti-allergic agent |
10/24/2000 | US6136572 Recombinant KAT enzyme and process for its preparation |
10/19/2000 | WO2000061561A1 Cyanoguanidine compounds |
10/18/2000 | EP1044187A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
10/18/2000 | EP0603251B1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions |
10/18/2000 | CN1270169A Benzopyrane derivatives and preparation thereof |
10/18/2000 | CN1057546C Reinforced rubber article production thereof and rubber composition suitable therefor |
10/17/2000 | US6133448 Aromatic compound is added to a solution of dinitrogen pentaoxide in an organic solvent and the provided reaction mixture is thereafter added into water comprising a nucleophile |
10/17/2000 | US6133285 Quinoline derivatives |
10/17/2000 | US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity |
10/17/2000 | US6133283 Mono- or polyenic carboxylic acid derivatives |
10/17/2000 | US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
10/17/2000 | US6133265 Treating physiological disorders associated with an excess of neuropeptide y, such as eating disorders, e.g., obesity, bulimia, and certain cardiovascular diseases, e.g., hypertension |
10/17/2000 | US6133264 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation |
10/17/2000 | US6133252 Fungicides for the control of take-all disease of plants |
10/17/2000 | US6132768 Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
10/17/2000 | CA2114300C Quinoline or quinazoline derivatives, their production and use |
10/12/2000 | WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
10/12/2000 | WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
10/12/2000 | WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE |
10/12/2000 | WO1999064039A9 Bradykinin antagonists |
10/12/2000 | WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
10/12/2000 | CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
10/12/2000 | CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof |
10/12/2000 | CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase |
10/11/2000 | EP1043326A1 Steroid receptor modulator compounds and methods |
10/11/2000 | EP1043325A1 Steroid receptor modulator compounds and methods |
10/11/2000 | EP1043315A1 Steroid receptor modulator compounds and methods |
10/11/2000 | EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
10/11/2000 | EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
10/11/2000 | EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
10/11/2000 | EP1041989A1 Novel cycloalkenyl substituted compounds |
10/11/2000 | EP1041986A1 Pharmaceutically active compound and methods of use |
10/11/2000 | EP1041979A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof |
10/11/2000 | CN1057297C Waterless crystallization of quinolone derivative and crystallization method of its 3/2 hydrate |
10/10/2000 | US6130231 Integrin receptor antagonists |
10/10/2000 | US6130230 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof |
10/10/2000 | US6130222 Analgesics |
10/10/2000 | CA2067475C Carbostyril derivatives and their use |
10/05/2000 | WO2000058405A2 Squaraine dyes |
10/05/2000 | WO2000042026B1 Non-peptide glp-1 agonists |
10/05/2000 | CA2366263A1 Squaraine dyes |
10/04/2000 | EP1041071A1 Methods for the preparation of coumarine derivatives |
10/04/2000 | EP1041066A1 Steroid receptor modulator compounds and methods |
10/04/2000 | EP1040097A1 Potassium channel openers |
10/04/2000 | EP1039884A1 A method for the prevention and treatment of stunned myocardium |
10/04/2000 | EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
10/04/2000 | EP0708773B1 Fused cycloalkylimidazopyridines |
10/04/2000 | EP0569384B2 Fungicides |
10/04/2000 | CN1268942A Sulfonamide compounds and medicinal use thereof |
10/03/2000 | US6127568 Phenylacetic acid derivatives, preparation thereof and intermediates thereof, and compositions containing them |
10/03/2000 | US6127403 An enzyme inhibitor for treating arteriosclerotic lesions of arteriosclerosis, hyperlipemia and diabetes, as well as ischemic diseases of brain, heart |
10/03/2000 | US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease |
10/03/2000 | US6127360 Antihistamines, antileukotrienes, antiinflammatory agents, antiasthmatic agents |
10/03/2000 | US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides |
09/28/2000 | WO2000056729A1 Chemokine recpetor binding heterocyclic compounds |
09/28/2000 | WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists |
09/28/2000 | WO2000056704A1 Hydroxamic and carboxylic acid derivatives |
09/28/2000 | CA2368047A1 Chemokine receptor binding heterocyclic compounds |
09/28/2000 | CA2367963A1 Hydroxamic and carboxylic acid derivatives |
09/27/2000 | EP1037879A1 Condensed pyridine derivatives |
09/27/2000 | EP1037878A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
09/27/2000 | EP1037865A1 Synthesis of cc-1065/duocarmycin analogs |
09/27/2000 | EP1037586A1 Utilization of onium aldehydes and onium ketones for dying fibers containing keratin |
09/27/2000 | CN1056832C Fused dihydropyridine derivate, its producing process, and its pharmaceutical composition |
09/26/2000 | US6124455 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
09/26/2000 | US6124297 Combatting insects or mites |
09/26/2000 | US6124251 Toilet bowl cleaning tablet |
09/21/2000 | WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |